Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 3Melanoma 2Urinary Bladder Neoplasms 1Spondylitis, Ankylosing 1Skin Carcinoma 1Signs and Symptoms 1Rectal Neoplasms 1Psoriasis 1Pancreatic Neoplasms 1Overweight 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Lymphedema 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Endometrial Neoplasms 1Crohn Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1

Interventions

Oxaliplatin 10Fluorouracil 9Capecitabine 8Leucovorin 6Nivolumab 4Cetuximab 4Specimen Handling 3Radiotherapy 3Magnetic Resonance Spectroscopy 3pembrolizumab 2fludarabine 2dostarlimab 2aldesleukin 2Trastuzumab 2Tomography, X-Ray Computed 2Surveys and Questionnaires 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Radiation 2Pemetrexed 2Magnetic Resonance Imaging 2Gemcitabine 2Electrocardiography 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2Bevacizumab 2ulixertinib 1tucatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Methods × 30 days × Clear all
NCT05056077 2026-05-18

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡